文献速递头颈外科

头颈癌患者静脉血栓栓塞症风险评估及其预测模型的建立

Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
PubMed 文献 · Head Neck · 2023-08-07

一项回顾性横断面研究纳入220例头颈癌患者,采用Lasso算法筛选变量并以多变量逻辑回归构建静脉血栓栓塞症列线图预测模型,内部验证显示C指数0.972、AUC 0.981,校准曲线与决策曲线分析显示模型预测概率与实际观察一致性良好且具有净获益。

要点

  • 头颈癌相关静脉血栓栓塞症发生率为2.8%(55/1967)。
  • Lasso算法筛选出手术、放化疗、D-二聚体、天冬氨酸转氨酶和球蛋白5个预测因子。
  • 列线图模型区分度良好,C指数0.972(95%CI 0.934-0.997),AUC 0.981(P<0.001,95%CI 0.964-0.998)。

核心结论

  • 本研究开发的高性能列线图模型可能有助于早期诊断头颈癌患者静脉血栓栓塞症风险,并指导个体化血栓预防决策。

研究设计与样本

  • 采用回顾性横断面研究设计,比较分析2018年1月至2021年12月期间的220例头颈癌患者。
  • 使用Lasso算法优化变量选择,并通过多变量逻辑回归分析建立预测头颈癌相关静脉血栓栓塞症的列线图模型。
  • 通过bootstrap重采样(1000次)对模型进行内部验证,并应用校准图和决策曲线分析评估预测模型的校准能力。

主要发现

  • 作者所在机构头颈癌相关静脉血栓栓塞症发生率为2.8%(55/1967)。
  • Lasso算法筛选出手术、放化疗、D-二聚体、天冬氨酸转氨酶和球蛋白5个危险因素变量作为预测因子。
  • 模型区分度良好,C指数为0.972(95%CI:0.934-0.997),受试者工作特征曲线下面积值为0.981(P<0.001,95%CI:0.964-0.998)。
  • 校准曲线显示预测概率与实际观察概率高度一致,决策曲线分析显示应用该列线图在临床实践中与净获益增加相关。

关键数值与推荐

  • 头颈癌相关静脉血栓栓塞症发生率为2.8%(55/1967)。
  • 列线图模型C指数0.972(95%CI:0.934-0.997),AUC 0.981(P<0.001,95%CI:0.964-0.998)。

临床怎么用

  • 作者认为该列线图模型可能有助于早期诊断头颈癌患者静脉血栓栓塞症风险,并指导个体化血栓预防决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Venous thromboembolism (VTE) is closely relevant to head and neck cancer (HNC) prognosis, but little data exist on the risk prediction of VTE in patients with HNC. OBJECTIVE: To study the risk factors regarding VTE in HNC patients and construct a nomogram model for its prediction. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional retrospective study was implemented to comparatively analyze 220 HNC patients from January 2018 to December 2021. The Lasso algorithm was used to optimize the selection of variables. A nomogram model for predicting HNC-associated VTE was established using multivariate logistic regression analysis. Internal validation of the model was performed by bootstrap resampling (1000 times). Calibration plot and decision curve analysis (DCA) were applied to evaluate the calibration capability of the prediction model. MAIN OUTCOME AND MEASURE: The demographics, medical history, blood biochemical indicators, and modalities of treatment were included for analysis. RESULTS: The incidence of HNC-associated VTE was 2.8% (55/1967) in authors' affiliation. Five variables of risk factors, including surgery, radiochemotherapy, D-dimer, aspartate transaminase, and globulin, were screened and selected as predictors by Lasso algorithm. A prediction model that incorporated these independent predictors was developed and presented as the nomogram. The model showed good discrimination with a C-index of 0.972 (95% CI: 0.934-0.997), and had an area under the receiver operating characteristic curve value of 0.981 (p < 0.001, 95% CI: 0.964-0.998). The calibration curve displayed good agreement of the predicted probability with the actual observed probability for HNC-associated VTE. The DCA plot showed that the application of this nomogram was associated with net benefit gains in clinical practice. CONCLUSIONS AND RELEVANCE: The high-performance nomogram model developed in this study may help early diagnose the risk of VTE in HNC patients and to guide individualized decision-making on thromboprophylaxis.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Li CX, He Q, Wang ZY, et al. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model. Head Neck. 2023. PMID: 37548087. doi:10.1002/hed.27475

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。